VBI Vaccines: Funding, Investors & Team (Sep 2026)
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
VBI Vaccines has raised $112M across 2 funding rounds on record, the most recent a Post-IPO Debt of $100M announced in Sep 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VBI Vaccines Company Profile and Key Stats
Latest funding round on record: Sep 2022.
VBI Vaccines Funding Rounds
VBI Vaccines raised $12.0M in an undisclosed round announced in May 2021.
1.3 years later, a Post-IPO Debt of $100M was announced in Sep 2022.
VBI Vaccines Founders and Leadership Team
Contact details for the VBI Vaccines team: 1 of 2 have an email address on file.
Start 14-day free trial →VBI Vaccines Funding Compared to Other Biotechnology Startups
VBI Vaccines' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VBI Vaccines in Biotechnology and Cambridge
Companies Similar to VBI Vaccines
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
VBI Vaccines Funding FAQs
What does VBI Vaccines do?
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
How much funding has VBI Vaccines raised?
VBI Vaccines has raised $112M across 2 rounds on record. The most recent is a Post-IPO Debt of $100M announced in Sep 2022.
When did VBI Vaccines last raise funding?
VBI Vaccines' most recent funding round on record is a Post-IPO Debt of $100M, announced in Sep 2022.
Who is the CEO of VBI Vaccines?
Jeff Baxter is listed as CEO at VBI Vaccines.
Where is VBI Vaccines headquartered?
VBI Vaccines is based in Cambridge, Massachusetts, United States.
How many employees does VBI Vaccines have?
VBI Vaccines is in the 101-250 employee band.
How does VBI Vaccines' funding compare to other Biotechnology startups?
VBI Vaccines' latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's VBI Vaccines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VBI Vaccines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.